Skip to content

Sonographically recognizable subclinical disease activity in children and adolescents with juvenile idiopathic arthritis and its correlation to the clinical course of the disease

Sonographically recognizable subclinical disease activity in children and adolescents with juvenile idiopathic arthritis and its correlation to the clinical course of the disease - JIASono

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036129
Enrollment
62
Registered
2025-02-19
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M08

Interventions

Group 1: In this study, children and adolescents with JIA will be examined in a double-blind, standardized manner using joint ultrasound in accordance with the inclusion criteria listed below, close t

Sponsors

Gesundheit Nord gGmbH, Klinikum Bremen-Mitte, Eltern-Kind Zentrum Prof. Hess, Kliniken für Kinder- und Jugendmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 16 Years

Inclusion criteria

Inclusion criteria: - Rheumatological diagnosis of JIA using the ILAR criteria - under drug therapy or the end of therapy <9 months ago

Exclusion criteria

Exclusion criteria: - Diagnosis change

Design outcomes

Primary

MeasureTime frame
The primary outcome measures are the semiquantitative sonographic representation of disease activity in patients with JIA in MSUS, especially in the form of synovitis, tenosynovitis, enthesitis, and possibly erosions as pathological findings.

Secondary

MeasureTime frame
Secondary endpoints are the retrospective evaluation of the correlation between clinical examination and sonographic findings at set time intervals.

Countries

Germany

Contacts

Public ContactÖvünc Tuna Bozkurt

Gesundheit Nord gGmbH, Klinikum Bremen-Mitte, Eltern-Kind Zentrum Prof. Hess, Kliniken für Kinder- und Jugendmedizin

oevuenctuna.bozkurt@gesundheitnord.de+4942149771222

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026